PROCYTE DX HEMATOLOGY ANALYZER

Procurement Summary

The National Institute of Allergy and Infectious Diseases {NIAID) conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. For more than 60 years, NIAID research has led to new therapies, vaccines, diagnostic tests, and other technologies that have improved the health of millions of people in the United States (U.S.) and around the world. NIAID has a unique mandate, which requires the Institute to respond to emerging public health threats. To facilitate its efforts, the NIAID has created the Integrated Research Facility {IRF) as a part of the National lnteragency Biodefense Campus located at Ft. Detrick, MD. The NIAID IRF is a specialized biocontainment facility with the appropriate infrastructure to support basic research and animal studies with various infectious disease agents including those requiring the highest level of biocontainment, (BSL-4), to evaluate therapeutics, vaccines and diagnostics as well as natural history and pathogenesis associated with these agents. The primary focus of the IRF is to manage, coordinate and facilitate the conduct of research with emerging infectious diseases and biodefense pathogens. The mission outcome is to develop improved medical outcomes for patients and develop medical countermeasures and control strategies for human health. The IRF has a procurement for a ProCyte Dx Hematology Analyzer is an automated hematology analyzer for animal blood that evaluates and provides the results of 27 parameters for each blood sample in approximately two minutes. The ProCyte Dx analyzer is for veterinary use only. The current requirements are as follows: • Research ProCyte Dx Analyzer • Delivery Fee: Vetlab Dx • Instrument Starter Packs

Yes

Yes